单细胞分析揭示参与慢性血栓栓塞性肺动脉高压的独特免疫细胞和平滑肌细胞群体
该研究对5例接受肺动脉内膜剥脱术患者的手术切除组织进行单细胞RNA测序,鉴定构成CTEPH血栓的多种细胞类型。发现巨噬细胞分为两个主要类别,较大群体以炎症信号上调为特征,预测促进肺血管重塑;CD4+和CD8+ T细胞可能参与慢性炎症;平滑肌细胞为异质性群体,其中肌成纤维细胞群表达纤维化标志物,伪时间分析预测其来源于其他平滑肌细胞簇。体外实验显示,从CTEPH纤维血栓物质中分离的内皮细胞、平滑肌细胞和肌成纤维细胞在血管生成潜力及增殖和凋亡速率方面与对照细胞表型不同。分析确定PAR1为连接血栓形成与CTEPH慢性肺栓塞的潜在治疗靶点,抑制PAR1可减少平滑肌细胞和肌成纤维细胞增殖与迁移。
要点
- 对5例肺动脉内膜剥脱术切除组织行单细胞RNA测序,鉴定出巨噬细胞、T细胞和平滑肌细胞等构成CTEPH血栓的多种细胞类型。
- 巨噬细胞分为两个主要类别,较大群体以炎症信号上调为特征,预测促进肺血管重塑。
- CD4+和CD8+ T细胞被鉴定,可能参与CTEPH慢性炎症。
- 平滑肌细胞为异质性群体,其中肌成纤维细胞簇表达纤维化标志物,伪时间分析预测其来源于其他平滑肌细胞簇。
- PAR1被确定为潜在治疗靶点,抑制PAR1可减少平滑肌细胞和肌成纤维细胞增殖与迁移。
适用人群与场景
- 接受肺动脉内膜剥脱术手术的CTEPH患者,切除组织用于单细胞RNA测序(5例患者)。
- 体外实验使用从CTEPH血栓和健康肺血管分离的细胞。
研究设计与关键结果
- 研究类型:单细胞RNA测序联合体外功能实验;样本量:5例患者的手术切除组织。
- 单细胞RNA测序鉴定构成CTEPH血栓的多种细胞类型,包括巨噬细胞、T细胞和平滑肌细胞。
- 巨噬细胞分为两个主要类别,较大群体以炎症信号上调为特征,预测促进肺血管重塑。
- 鉴定出CD4+和CD8+ T细胞,可能参与CTEPH慢性炎症。
- 平滑肌细胞为异质性群体,其中肌成纤维细胞簇表达纤维化标志物,伪时间分析预测其来源于其他平滑肌细胞簇。
- 从CTEPH纤维血栓物质分离培养的内皮细胞、平滑肌细胞和肌成纤维细胞在血管生成潜力及增殖和凋亡速率方面与对照细胞表型不同。
- PAR1被确定为连接血栓形成与CTEPH慢性肺栓塞的潜在治疗靶点,抑制PAR1可减少平滑肌细胞和肌成纤维细胞增殖与迁移。
证据类型、等级与局限
- 证据类型:单细胞RNA测序联合体外实验研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现提示CTEPH发病模型类似动脉粥样硬化,即巨噬细胞和T细胞促进的慢性炎症通过平滑肌细胞调节驱动血管重塑,并提出药理学靶向该疾病的新途径。
- 作者分析确定PAR1为潜在治疗靶点,抑制PAR1可减少平滑肌细胞和肌成纤维细胞增殖与迁移。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Chronic thromboembolic pulmonary hypertension (CTEPH) is a sequela of acute pulmonary embolism (PE) in which the PE remodels into a chronic scar in the pulmonary arteries. This results in vascular obstruction, pulmonary microvasculopathy, and pulmonary hypertension. Objectives: Our current understanding of CTEPH pathobiology is primarily derived from cell-based studies limited by the use of specific cell markers or phenotypic modulation in cell culture. Therefore, our main objective was to identify the multiple cell types that constitute CTEPH thrombusy and to study their dysfunction. Methods: Here we used single-cell RNA sequencing of tissue removed at the time of pulmonary endarterectomy surgery from five patients to identify the multiple cell types. Using in vitro assays, we analyzed differences in phenotype between CTEPH thrombus and healthy pulmonary vascular cells. We studied potential therapeutic targets in cells isolated from CTEPH thrombus. Measurements and Main Results: Single-cell RNA sequencing identified multiple cell types, including macrophages, T cells, and smooth muscle cells (SMCs), that constitute CTEPH thrombus. Notably, multiple macrophage subclusters were identified but broadly split into two categories, with the larger group characterized by an upregulation of inflammatory signaling predicted to promote pulmonary vascular remodeling. CD4+ and CD8+ T cells were identified and likely contribute to chronic inflammation in CTEPH. SMCs were a heterogeneous population, with a cluster of myofibroblasts that express markers of fibrosis and are predicted to arise from other SMC clusters based on pseudotime analysis. Additionally, cultured endothelial, smooth muscle, and myofibroblast cells isolated from CTEPH fibrothrombotic material have distinct phenotypes from control cells with regard to angiogenic potential and rates of proliferation and apoptosis. Last, our analysis identified PAR1 (protease-activated receptor 1) as a potential therapeutic target that links thrombosis to chronic PE in CTEPH, with PAR1 inhibition decreasing SMC and myofibroblast proliferation and migration. Conclusions: These findings suggest a model for CTEPH similar to atherosclerosis, with chronic inflammation promoted by macrophages and T cells driving vascular remodeling through SMC modulation, and suggest new approaches for pharmacologically targeting this disease.
参考来源
- Viswanathan G, Kirshner HF, Nazo N, et al. Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension. Am J Respir Crit Care Med. 2023. PMID: 36803741. doi:10.1164/rccm.202203-0441OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。